共 116 条
[1]
Lazarus B(2016)Proton pump inhibitor use and the risk of chronic kidney disease JAMA Intern Med 176 238-246
[2]
Chen Y(2015)Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: a systematic review and meta-analysis Infect Control Hosp Epidemiol 36 132-141
[3]
Wilson FP(2014)Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis Gut 63 552-558
[4]
Sang Y(2011)Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies Ann Fam Med 9 257-267
[5]
Chang AR(2016)Association of proton pump inhibitors with risk of dementia JAMA Neurol 73 410-416
[6]
Coresh J(2018)Proton pump inhibitors and cardiovascular events: a systematic review Heart Lung Circ 27 443-450
[7]
Grams ME(2016)Proton pump inhibitor prescribing patterns in the UK: a primary care database study Pharmacoepidemiol Drug Saf 25 1079-1087
[8]
Furuya-Kanamori L(2015)A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice Br J Clin Pharmacol 80 1254-1268
[9]
Stone JC(2017)Effectiveness of interventions to deprescribe inappropriate proton pump inhibitors in older adults Drugs Aging 34 265-287
[10]
Clark J(2012)Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review PLoS One 7 e43617-500